A likely explanation for the differences observed in survival between cardiomyocyte-specific KO and whole body KO mice is that the loss of CAP2 in tissues other than the heart affects the secretion of factors, such as sex hormones, that can influence the progression of cardiac conduction disease. The gene discussed is CAP2; the disease is heart conduction disease.